ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Alnylam Pharmaceuticals
The Program Lead, Development - Rare Disease provides strategic and operational leadership for early-stage rare disease programs in the hepatobiliary space. This role involves building integrated development strategies, leading cross-functional teams, and making investment decisions based on clinical and scientific evidence. The position requires an experienced drug development leader to navigate ambiguity and drive programs through critical early clinical milestones.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alnylam Pharmaceuticals.
31% above the average for this role
Clinical Scientist Rare Disease
Excelya
AI Biologist - Rare Disease
DOOR
Senior Director, Head of Inflammation & Rare Disease in Medical & Science
Zealand Pharma
Senior Medical Science Liaison (Central) - Rare Disease
Zevra
Medical Science Liaison, Rare Disease (Pacific Northwest)
Ipsen
Medical Science Liaison, Rare Disease (Central)
Ipsen